跳至主要内容
临床试验/EUCTR2020-001304-42-GB
EUCTR2020-001304-42-GB进行中(未招募)1 期

Efficacy of Nitric Oxide in Stroke -2 - ENOS-2

niversity of Nottingham0 个研究点目标入组 120 人开始时间: 2020年7月10日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 100 adults (=18 years) with ischaemic stroke and compatible CT (MR) scan.
  • 20 adults (=18 years) with imaging-confirmed intracerebral haemorrhage (ICH) and maximum haematoma length <5cm (recruited for safety only).
  • Treatment 3-5 hours post ictus (or from when last seen free of stroke symptoms)
  • Systolic BP >120 mmHg
  • Waiver of consent for treatment to ensure GTN given in 3-5 hour time-window (and thrombolysis not delayed if ischaemic stroke).
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 90

排除标准

  • Patient from a nursing home
  • Glucose (BM stix or equivalent) <3 mmol/l
  • Glasgow coma scale <8
  • Witnessed seizure at presentation
  • Known life expectancy <6 months.
  • Known stroke mimic, aneurysmal subarachnoid haemorrhage, or haemorrhage due to venous thrombosis
  • Systolic blood pressure <120 mmHg
  • Known allergy to glyceryl trinitrate (Transiderm Nitro) patch
  • Known sensitivity to Duoderm hydrocolloid dressing
  • Pregnant or breast-feeding
  • Planned for palliative care only
  • Known previous enrolment in ENOS-2

研究者

发起方
niversity of Nottingham

相似试验